Logo image
Reversible severe ovarian enlargement in an infant with significant insulin resistance
Journal article   Open access   Peer reviewed

Reversible severe ovarian enlargement in an infant with significant insulin resistance

Lillian Lai, Amir Mikhchi, Anna Ryabets-Lienhard, Mitchell E Geffner, Clement Cheung and Danielle Guiffre
Radiology case reports, Vol.16(7), pp.1760-1765
05/01/2021
DOI: 10.1016/j.radcr.2021.03.067
PMCID: PMC8111256
PMID: 34007398
url
https://doi.org/10.1016/j.radcr.2021.03.067View
Published (Version of record) Open Access

Abstract

The extent, severity, and radiological findings of ovarian growth in infants with genetic syndromes of insulin resistance have not been fully described. We report a rare case of reversible massive ovarian enlargement in a female infant with a congenital insulin resistance syndrome, likely Rabson-Mendenhall syndrome given the less clinically severe course. The patient presented with neonatal diabetes with hyperinsulinemia and hyperglycemia due to congenital insulin resistance. She developed increasing severe bilateral ovarian enlargement which peaked at 4 months of age, followed by gradual decrease in size of the ovaries following treatment with insulin-sensitizing drugs and improved hyperinsulinemia. The ovarian enlargement is postulated to be secondary to the trophic effects of insulin acting in a gonadotropin-independent mechanism. Hyperinsulinemia in congenital insulin resistance can also result in hypertrophy of other organs. Understanding the pathophysiology behind massive ovarian enlargement in the setting of congenital insulin resistance syndromes can help guide appropriate therapy.
Donohue Enlargement Insulin resistance Ovarian Pediatric Rabson-Mendenhall

Details

Metrics

2 Record Views
Logo image